{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:17:13Z","timestamp":1795112233978,"version":"4.10.3"},"reference-count":19,"publisher":"Wiley","issue":"s5","license":[{"start":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T00:00:00Z","timestamp":1236902400000},"content-version":"vor","delay-in-days":9994,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacologica et Toxicologica"],"published-print":{"date-parts":[[1981,11]]},"abstract":"<jats:p><jats:bold>Abstract<\/jats:bold> A method for the simultaneous quantitation of metrifonate (0,0\u2010dimethyl\u2010(1\u2010hydroxy\u20102,2,2\u2010trichloroethyl)\u2010phosphonate) and dichlorvos (2,2\u2010dichlorovinyl dimethyl phosphate, DDVP) in human blood has been worked out. It is based upon multiple labelling of the compounds with deuterium and gas phase analysis using the mass spectrometer as a selective detector. The amount of DDVP in plasma is about 1% of the amount of metrifonate. In erythrocytes the corresponding amount of DDVP is 0.5% or less of metrifonate. Both compounds reach peak levels in blood within two hours after oral dosing and are detectable for at least eight hours. Cholinesterase activity in plasma reaches zero levels within 15 min. and remains inhibited for more than eight hours. Red blood cell cholinesterase is inhibited only 60\u201080%. According to kinetic calculations, clearance of metrifonate occurs primarily via dichlorvos. If dichlorvos is the only active component, which in all likelihood it is, it's slow release may be important in the schistosomicidal effect. Clinical data in seven metrifonate treated patients revealed that mild vertigo subsiding in a few hours was the most common side effect.<\/jats:p>","DOI":"10.1111\/j.1600-0773.1981.tb03256.x","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T14:05:41Z","timestamp":1280412341000},"page":"79-86","source":"Crossref","is-referenced-by-count":42,"title":["Levels of Metrifonate and Dichlorvos in Plasma and Erythrocytes during Treatment of Schistosomiasis with Bilarcil\u00ae"],"prefix":"10.1111","volume":"49","author":[{"given":"I.","family":"Nordgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Holmstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.\u2010M.","family":"Pettersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,13]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00316489"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(78)90322-4"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(70)90075-X"},{"key":"e_1_2_1_5_1","first-page":"738","article-title":"Carboxylesterase inhibition as an indicator of malathion potentiation in mice","volume":"176","author":"Cohen S. D.","year":"1971","journal-title":"J. Pharmacol."},{"key":"e_1_2_1_6_1","first-page":"399","article-title":"Malathionase I. Activity and inhibition","volume":"41","author":"Cook J. W.","year":"1958","journal-title":"J. Ass. Offic. Agri. Chem."},{"key":"e_1_2_1_7_1","first-page":"209","article-title":"Metrifonate in urinary schistosomiasis","volume":"41","author":"Davis A.","year":"1969","journal-title":"Bull. Wld. Hlth. Org."},{"key":"e_1_2_1_8_1","first-page":"96","article-title":"Marked potentiation in mammalian toxicity from simultaneous administration of two anticholinesterase compounds","volume":"121","author":"Frawley J. P.","year":"1957","journal-title":"J. Pharmacol."},{"key":"e_1_2_1_9_1","first-page":"443","volume-title":"Stable isotopes","author":"Holmstedt B.","year":"1979"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00351766"},{"key":"e_1_2_1_11_1","first-page":"579","article-title":"Not\u00e9 preliminaire sur la toxicit\u00e9 pour l'homme d'un insecticide organophosphor\u00e9 (Dipterex)","volume":"22","author":"Lebrun A.","year":"1960","journal-title":"Bull. Wld. Hlth. Org."},{"key":"e_1_2_1_12_1","first-page":"352","article-title":"Malathion inhibition of esterases as a determinant of malathion toxicity","volume":"156","author":"Murphy S. D.","year":"1967","journal-title":"J. Pharmacol."},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-96-23617"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00351767"},{"issue":"3","key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4269\/ajtmh.1980.29.426","article-title":"Plasma levels of metrifonate and dichlorvos during treatment of schistosomiasis with Bilarcil\u00ae","volume":"29","author":"Nordgren I.","year":"1980","journal-title":"Amer. J. Trop. Med. Hyg."},{"key":"e_1_2_1_16_1","unstructured":"Plestina R.:Temephos\/metrifonate combined exposure.Wld. Hlth. Org. Geneva 3\u20139 October 1978 PDS\/EC25\/78.32."},{"key":"e_1_2_1_17_1","first-page":"747","article-title":"Effect of metrifonate on blood cholinesterases in children during the treatment of schistosomiasis","volume":"46","author":"Plestina R.","year":"1972","journal-title":"Bull. Wld. Hlth. Org."},{"key":"e_1_2_1_18_1","volume-title":"Die Entwicklung neuer insektizider Phosphorsaure\u2010Ester","author":"Schrader G.","year":"1963"},{"key":"e_1_2_1_19_1","first-page":"827","article-title":"The treatment of bilharziasis and other intestinal parasites with Dipterex. A preliminary report on one hundred cases","volume":"46","author":"Talaat S. M.","year":"1963","journal-title":"J. Egypt. Med. Ass."},{"key":"e_1_2_1_20_1","unstructured":"Wld. Hlth. Org. Techn. Rep. Ser. 1973 515 World Health Organization report: Schistosomiasis control"}],"container-title":["Acta Pharmacologica et Toxicologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0773.1981.tb03256.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0773.1981.tb03256.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T11:56:32Z","timestamp":1695729392000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0773.1981.tb03256.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,11]]},"references-count":19,"journal-issue":{"issue":"s5","published-print":{"date-parts":[[1981,11]]}},"alternative-id":["10.1111\/j.1600-0773.1981.tb03256.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0773.1981.tb03256.x","archive":["Portico"],"relation":{},"ISSN":["0001-6683"],"issn-type":[{"value":"0001-6683","type":"print"}],"subject":[],"published":{"date-parts":[[1981,11]]}}}